Philip_Mease

Dr. Philip Mease MD

Director of Rheumatology Research at the Swedish Medical Center and Providence St Joseph Health and Clinical Professor at the University of Washington School of Medicine, Seattle, WA., Director of Rheumatology Research at the Swedish Medical Center and Providence St Joseph Health and Clinical Professor at the University of Washington School of Medicine, Seattle, WA.

Dr. Mease is Director of Rheumatology Research at the Swedish Medical Center and Providence St Joseph Health and Clinical Professor at the University of Washington School of Medicine, Seattle, WA. His clinical practice is based at Seattle Rheumatology Associates. Dr. Mease earned his undergraduate and medical degrees at Stanford University, Stanford, CA and completed his residency in internal medicine and a fellowship in rheumatology at the University of Washington School of Medicine.

Dr. Mease’s research interests include psoriatic arthritis (PsA), spondyloarthritis (SpA), rheumatoid arthritis (RA), osteoarthritis (OA), fibromyalgia (FM) and osteoporosis, focusing on disease state, outcome measure development and the efficacy and safety of emerging therapies for these conditions. He has authored over 500 journal articles, book chapters and many hundreds of abstracts, and edited textbooks on PsA and axial SpA. He is a reviewer for multiple journals including New England Journal of Medicine, The Lancet, Arthritis & Rheumatology, Arthritis Care & Research, Annals of the Rheumatic Diseases, The Journal of Rheumatology and Seminars in Arthritis and Rheumatism. Dr. Mease is a prolific international speaker at academic congresses, educator for rheumatologists and dermatologists, and is considered an international opinion leader on SpA.

Dr. Mease is a past president and founding organizer of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and is a member of the Assessment of Spondyloarthritis International Society and the Spondyloarthritis Research and Treatment Network. He has also been active in the Outcome Measures in Rheumatology (OMERACT) research organization as co-chair of the PsA and chronic pain working groups and as a member of the steering committee.


Appearances